Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Medical Properties Trust Inc is a reit-healthcare facilities business based in the US. Medical Properties Trust shares (MPW) are listed on the NYSE and all prices are listed in US Dollars. Medical Properties Trust employs 106 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$20.07|
|52-week range||$15.27 - $22.21|
|50-day moving average||$20.47|
|200-day moving average||$21.04|
|Wall St. target price||$23.46|
|Dividend yield||$1.1 (5.38%)|
|Earnings per share (TTM)||$0.93|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-10)||-4.70%|
|1 month (2021-08-19)||2.09%|
|3 months (2021-06-18)||1.26%|
|6 months (2021-03-19)||-4.11%|
|1 year (2020-09-18)||17.99%|
|2 years (2019-09-18)||6.25%|
|3 years (2018-09-18)||35.88%|
|5 years (2016-09-16)||42.54%|
Valuing Medical Properties Trust stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medical Properties Trust's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Medical Properties Trust's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 22x. In other words, Medical Properties Trust shares trade at around 22x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Medical Properties Trust's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.93. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Medical Properties Trust's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Medical Properties Trust's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.3 billion.
The EBITDA is a measure of a Medical Properties Trust's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.4 billion|
|Operating margin TTM||67.45%|
|Gross profit TTM||$1.2 billion|
|Return on assets TTM||3.5%|
|Return on equity TTM||6.81%|
|Market capitalisation||$12 billion|
TTM: trailing 12 months
There are currently 24.6 million Medical Properties Trust shares held short by investors – that's known as Medical Properties Trust's "short interest". This figure is 12.1% up from 22.0 million last month.
There are a few different ways that this level of interest in shorting Medical Properties Trust shares can be evaluated.
Medical Properties Trust's "short interest ratio" (SIR) is the quantity of Medical Properties Trust shares currently shorted divided by the average quantity of Medical Properties Trust shares traded daily (recently around 3.2 million). Medical Properties Trust's SIR currently stands at 7.81. In other words for every 100,000 Medical Properties Trust shares traded daily on the market, roughly 7810 shares are currently held short.
However Medical Properties Trust's short interest can also be evaluated against the total number of Medical Properties Trust shares, or, against the total number of tradable Medical Properties Trust shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Medical Properties Trust's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Medical Properties Trust shares in existence, roughly 40 shares are currently held short) or 0.0418% of the tradable shares (for every 100,000 tradable Medical Properties Trust shares, roughly 42 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Medical Properties Trust.
Find out more about how you can short Medical Properties Trust stock.
Dividend payout ratio: 66.47% of net profits
Recently Medical Properties Trust has paid out, on average, around 66.47% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 5.47% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Medical Properties Trust shareholders could enjoy a 5.47% return on their shares, in the form of dividend payments. In Medical Properties Trust's case, that would currently equate to about $1.1 per share.
Medical Properties Trust's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Medical Properties Trust's most recent dividend payout was on 13 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 14 September 2021 (the "ex-dividend date").
Over the last 12 months, Medical Properties Trust's shares have ranged in value from as little as $15.268 up to $22.2084. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Medical Properties Trust's is 0.53. This would suggest that Medical Properties Trust's shares are less volatile than average (for this exchange).
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 431 facilities and roughly 43,000 licensed beds in nine countries and across four continents on a pro forma basis. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. .
Everything we know about the MiNK Therapeutics IPO, plus information on how to buy in.
Everything we know about the Wetouch Technology IPO, plus information on how to buy in.
Everything we know about the Life Time Group Holdings IPO, plus information on how to buy in.
Everything we know about the Slinger Bag IPO, plus information on how to buy in.
Everything we know about the NSTS Bancorp IPO, plus information on how to buy in.
Everything we know about the Volcon IPO, plus information on how to buy in.
Everything we know about the Thomas James Homes IPO, plus information on how to buy in.
Everything we know about the FGI Industries IPO, plus information on how to buy in.
Everything we know about the Zhong Yang Financial Group IPO, plus information on how to buy in.
Everything we know about the Exscientia Ltd IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.